Log in

214450 PharmaResearch Co., Ltd. KRX · South Korea

PharmaResearch Co. (214450) news

PharmaResearch Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 214450, recorded under South Korea. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest PharmaResearch Co. news

We have not published a story on PharmaResearch Co. yet. When there is news, it will appear here.

Questions about PharmaResearch Co.

What is the ticker symbol of PharmaResearch Co.?

PharmaResearch Co., Ltd. trades under the ticker 214450 on KRX.

Where is PharmaResearch Co. listed?

PharmaResearch Co., Ltd. is listed on KRX.

Which country or territory is PharmaResearch Co. listed under?

Our directory records PharmaResearch Co., Ltd. under South Korea.

What does PharmaResearch Co. do?

Our directory classifies PharmaResearch Co., Ltd. as: Mixed biopharma / other operations. This is a directory classification, not a description of the pipeline.

What is the ISIN of PharmaResearch Co.?

The ISIN recorded for PharmaResearch Co., Ltd. is KR7214450009.

Does aibio.space cover PharmaResearch Co.?

aibio.space lists PharmaResearch Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to PharmaResearch Co.?

Companies in our directory listed in the same country and business area as PharmaResearch Co.: Cellromax Science Co., KolmarBNH Co., Prestige Biologics Co., Peptron, HUONS CO., LTD, Dongsung Pharmaceutical Co..

Investor discussion: PharmaResearch Co.

Members talk about PharmaResearch Co. (214450). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:214450 on TradingView.

Listing details

PharmaResearch Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 214450, recorded under South Korea. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
PharmaResearch Co., Ltd.
Ticker
214450
Listing
KRX
Country or territory
South Korea
Business scope
Mixed biopharma / other operations
ISIN
KR7214450009
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.